PROFOUND MEDICAL CORP. Operating Expenses
PROFOUND MEDICAL CORP. (PROF) reported Operating Expenses of $13.01 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- PROFOUND MEDICAL CORP. operating expenses for the quarter ending 2026-06-30 was $13.01M, a 15.63% decline year-over-year.
- PROFOUND MEDICAL CORP. operating expenses for the quarter ending 2026-03-31 was $11.85M, a 8.96% decline year-over-year.
- PROFOUND MEDICAL CORP. operating expenses for the quarter ending 2025-12-31 was $11.36M, a 0.47% increase year-over-year.
- PROFOUND MEDICAL CORP. operating expenses for the quarter ending 2025-09-30 was $12.84M, a 19.08% increase year-over-year.
- PROFOUND MEDICAL CORP. operating expenses for fiscal 2025 was $52.65M, a 31.29% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. operating expenses for fiscal 2024 was $40.10M, a 21.65% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. operating expenses for fiscal 2023 was $32.96M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $13.01M 10-Q · filed 2026-08-06 | $24.87M 10-Q · filed 2026-08-06 | $36.23M derived: sum of 3 quarters · filed 2026-08-06 | $49.07M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $11.85M 10-Q · filed 2026-05-07 | $23.21M derived: sum of 2 quarters · filed 2026-05-07 | $36.06M derived: sum of 3 quarters · filed 2026-05-07 | $51.48M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $11.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $24.20M derived: sum of 2 quarters · filed 2026-03-05 | $39.63M derived: sum of 3 quarters · filed 2026-08-06 | $52.65M 10-K · filed 2026-03-05 |
| 2025-09-30 | $12.84M 10-Q · filed 2025-11-13 | $28.27M derived: sum of 2 quarters · filed 2026-08-06 | $41.29M 10-Q · filed 2025-11-13 | $52.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $15.42M 10-Q · filed 2026-08-06 | $28.44M 10-Q · filed 2026-08-06 | $39.75M derived: sum of 3 quarters · filed 2026-08-06 | $50.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $13.02M 10-Q · filed 2026-05-07 | $24.33M derived: sum of 2 quarters · filed 2026-05-07 | $35.11M derived: sum of 3 quarters · filed 2026-05-07 | $44.38M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $11.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $22.09M derived: sum of 2 quarters · filed 2026-03-05 | $31.36M derived: sum of 3 quarters · filed 2026-03-05 | $40.10M 10-K · filed 2026-03-05 |
| 2024-09-30 | $10.79M 10-Q · filed 2025-11-13 | $20.05M derived: sum of 2 quarters · filed 2025-11-13 | $28.79M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $9.26M 10-Q · filed 2025-08-14 | $18.01M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $8.74M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $32.96M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |